Navigation Links
Pathways Pharmacist Denise Schoenberger Honored for Healthcare Excellence by Silicon Valley Business Journal
Date:8/27/2013

Sunnyvale, CA (PRWEB) August 27, 2013

Denise Schoenberger, a clinical pharmacist at Pathways Home Health & Hospice, was honored by the Silicon Valley Business Journal for Excellence in Healthcare for her role in establishing the Pharmacist Assisted Transition Home (PATH) program. PATH is an innovative medication management program where a pharmacist makes house calls as part of a home health nursing team that provides patient care from hospital to home. Schoenberger was one of six healthcare professionals recognized by the Silicon Valley Business Journal for leadership and creativity in Santa Clara County.

PATH is a joint venture with Sequoia Hospital, a Dignity Health member, and has been successfully keeping at risk patients in their homes and preventing them from being re-hospitalized. Pathways Home Health & Hospice has been affiliated with Sequoia and El Camino Hospitals since 1986.

As the program’s pharmacist, Schoenberger visits patients at Sequoia Hospital when they are preparing for discharged. She provides them with medication education and guidance to prepare them for a smooth transition to home. She then visits the same patients again in their homes, where she coaches both the patients and their caregivers about medication management and how to take an active role in their healthcare.

“Denise is a key member of our home health nursing team,” said Georgia Rock, COO at Pathways Home Health & Hospice. “She shares her pharmacological expertise to create the best care plan possible for our patients. Her approach to patient care has resulted in many of our patients staying home and avoiding re-hospitalization. This award is well deserved.”

Pathways Home Health & Hospice has several transition care programs in addition to PATH. Many of these programs address the unique needs of older adults suffering from chronic illness. Without focused intervention, these patients are at a higher risk of medical emergencies leading to re-hospitalization. Pathways has implemented these evidence-based programs to help this high risk group of patients.

About Pathways Home Health & Hospice

Pathways Home Health & Hospice is a non-profit, community-based organization with more than 36 years of assisting Bay Area families. Pathways was founded in 1977 by a group of Stanford physicians and community members who saw the need for professional care at home. That first year, Pathways served 12 patients. Pathways now serves over 5,000 families a year in San Francisco, Alameda, Santa Clara, San Mateo and Contra Costa Counties.

Affiliated with El Camino and Sequoia Hospitals since 1986, Pathways Home Health & Hospice is accredited by The Joint Commission, and is a member of the Visiting Nurse Association of America, California Hospice & Palliative Care Association, and the California Association of Health Services at Home. Pathways Home Health & Hospice is a designated 2012 HomeCare Elite Agency for Quality Care.

Read the full story at http://www.prweb.com/releases/DeniseSchoenberger/Pharmacist/prweb11063968.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Los Altos Community Foundation Grant Supports Pathways Hospice
2. Pathways Bronwyn Calkins Honored with the 2013 Lillian O’Brien Award for Home Health Excellence
3. Pathways Hospice Offers Reflection, Comfort and Healing at Evening of Remembrance Memorial Service in Los Altos, California
4. Pathways Hospice Recognizes Sponsors of Bridge to Caring 2013
5. Details of gene pathways suggest fine-tuning drugs for child brain tumors
6. Tips for Making the Holidays Safer and Calmer for Dementia Patients from Pathways Home Health & Hospice
7. Pathways Home Health & Hospice Receives 2012 HomeCare Elite Top Honor for Quality Care
8. Investigational agent targets gene signaling pathways to improve response for patients with CLL
9. Optogenetics illuminates pathways of motivation through brain, Stanford study shows
10. How tumor cells create their own pathways
11. Following the genomic pathways to stop the spread of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... ... , is pleased to announce a new online course entitled Personal & ... practical insights and evidence-based strategies for achieving optimal well-being and teaches students how ...
(Date:6/20/2017)... ... , ... Kenneth Mayer, MD, has been appointed a new Editor-in-Chief of the ... the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among ... and Co-Chair of The Fenway Institute, a member of the US President’s Emergency ...
(Date:6/20/2017)... York, NY (PRWEB) , ... June 20, 2017 , ... ... today their continued expansion and success in the clinical trials market. Similar to its ... a track record in the clinical trials marketplace by proving the value of eVisits ...
(Date:6/20/2017)... ... June 20, 2017 , ... Dr. Manju R. Kejriwal ... leading-edge care, whether or not they have a referral. Dr. Kejriwal offers state-of-the-art ... laser, she targets bacteria and damaged tissue without affecting the surrounding tissue. This ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... (AHN) Jefferson Hospital is providing physicians with advanced capabilities for diagnosing and treating ... than traditional MRIs, enabling doctors to get a more accurate look inside the ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
Breaking Medicine Technology: